Ensign Group Faces Class Action Lawsuit; Investors May Seek Lead Plaintiff Role
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against The Ensign Group, Inc. Investors who have suffered substantial losses may seek to serve as lead plaintiff.
The law firm Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against The Ensign Group, Inc. The lawsuit is open to purchasers or acquirers of the company's publicly traded securities between February 10, 2022, and June 18, 2026.
Investors who experienced significant losses have until December 7, 2026, to file a motion to be appointed as the lead plaintiff in the case. The suit charges The Ensign Group and certain of its top executives with alleged violations of the Securities Exchange Act of 1934.
The lawsuit alleges that the company made false and misleading statements and failed to disclose critical information about its business practices. Specifically, it claims Ensign Group's model relies on the neglect of elderly residents, leading to insufficient care, including lack of food and medical attention, and resident deaths.
Further allegations include that Ensign Group defrauded Medicare and Medicaid by accepting federal funds for patients needing high levels of care and then neglecting them. The suit also claims the company falsified hours worked by certified nursing assistants and illegally used the licenses of administrators not present at its facilities.
The class action stems from reports published in June 2026 by Hunterbrook Media and Muddy Waters Research, which detailed allegations of patient neglect, hunger, and improper facility management. These reports led to a significant decline in The Ensign Group's stock price.